根据最新提交至美国证券交易委员会的文件披露，SANUWAVE Health, Inc.审计委员会经调查后正式认定，公司先前发布的多个会计期间财务报告存在重大瑕疵，不再适合作为投资决策依据。此次涉及财报期间的具体范围尚未公开披露，但这一结论意味着相关历史财务数据需要重新审计并可能面临调整。公司表示将尽快完成财务重述工作，并强调正在加强内部控制与财务报告流程以确保信息准确性。
根据最新提交至美国证券交易委员会的文件披露，SANUWAVE Health, Inc.审计委员会经调查后正式认定，公司先前发布的多个会计期间财务报告存在重大瑕疵，不再适合作为投资决策依据。此次涉及财报期间的具体范围尚未公开披露，但这一结论意味着相关历史财务数据需要重新审计并可能面临调整。公司表示将尽快完成财务重述工作，并强调正在加强内部控制与财务报告流程以确保信息准确性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.